Irinotecan (CPT-11): Pharmacology and clinical applications

被引：66

作者：

Masuda, N

Kudoh, S

Fukuoka, M

机构：

[1] OSAKA CITY UNIV,SCH MED,DEPT INTERNAL MED 1,ABENO KU,OSAKA 545,JAPAN

[2] OSAKA CITY GEN HOSP,DEPT PULM MED & MED ONCOL,MIYAZAKI UNIV,OSAKA,JAPAN

来源：

CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | 1996年 / 24卷 / 01期

关键词：

D O I：

10.1016/1040-8428(96)00201-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：3 / 26

页数：24

共 114 条

[1] PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS [J].

ABIGERGES, D ;

CHABOT, GG ;

ARMAND, JP ;

HERAIT, P ;

GOUYETTE, A ;

GANDIA, D .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :210-221

[2] IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA [J].

ABIGERGES, D ;

ARMAND, JP ;

CHABOT, GG ;

DACOSTA, L ;

FADEL, E ;

COTE, C ;

HERAIT, P ;

GANDIA, D .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :446-449

[3] CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J].

ANDOH, T ;

ISHII, K ;

SUZUKI, Y ;

IKEGAMI, Y ;

KUSUNOKI, Y ;

TAKEMOTO, Y ;

OKADA, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5565-5569

[4] IDENTIFICATION OF THE METABOLITES OF IRINOTECAN, A NEW DERIVATIVE OF CAMPTOTHECIN, IN RAT BILE AND ITS BILIARY-EXCRETION [J].

ATSUMI, R ;

SUZUKI, W ;

HAKUSUI, H .

XENOBIOTICA, 1991, 21 (09) :1159-1169

[5] UNKNOTTING THE COMPLEXITIES OF MULTIDRUG RESISTANCE - THE INVOLVEMENT OF DNA TOPOISOMERASES IN DRUG-ACTION AND RESISTANCE [J].

BECK, WT .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (22) :1683-1685

[6] SEQUENTIAL ADMINISTRATION OF CAMPTOTHECIN AND ETOPOSIDE CIRCUMVENTS THE ANTAGONISTIC CYTOTOXICITY OF SIMULTANEOUS DRUG ADMINISTRATION IN SLOWLY GROWING HUMAN COLON-CARCINOMA HT-29 CELLS [J].

BERTRAND, R ;

OCONNOR, PM ;

KERRIGAN, D ;

POMMIER, Y .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :743-748

[7]

BISSERY MC, 1992, 7TH P NCI EORTC S NE, P82

[8]

BONNETERRE J, 1993, P AN M AM SOC CLIN, V12, P94

[9] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].

BRONCHUD, MH ;

SCARFFE, JH ;

THATCHER, N ;

CROWTHER, D ;

SOUZA, LM ;

ALTON, NK ;

TESTA, NG ;

DEXTER, TM .

BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813

[10]

BUGAT R, 1995, P AN M AM SOC CLIN, V14, P222

← 1 2 3 4 5 6 7 8 9 10 →